Por: MarketWatch Business October 27, 2022
“Three transactions shows deals can get done,” Litchfield says. “Where science and value align, we will act.” Merck shares were up 1.6% on Thursday, trading at a flat $100 per share, after the company that beat Wall Street expectations. Merck’s sales were $15 billion for the third quarter, beating the analyst consensus estimate of $14.1 billion, and up 14% from the same quarter last year. Non-GAAP earnings were $1.85 per share, better... + full article
Associated Press USA Health October 27, 2022
Merck turned in a better-than-expected third quarter and raised its 2022 forecast as the drugmaker’s top seller brought in over a third of its revenue. Sales of the cancer fighter Keytruda grew 20% to more than $5.4 billion in the quarter and would have jumped 26% without the... + más
Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients | CNBC
Merck Says Health Canada Granted Approval For KEYTRUDA To Treat Renal Cell Carcinoma | RTTNews
Forbes USA Business October 20, 2022
Seattle, Washington, USA - May 27, 2012: A sign indicates Nordstrom and its founding date. ... [+] Nordstrom is headquartered in Seattle, Washington.Getty Anne Bramman, CFO of Nordstrom is leaving the company on December 2 after the third quarter results are announced. Bramman... + más
Princess Anne makes surprise visit to New York City | ABC News
Bob From Accounting Saves The Day | Forbes
The Boston Globe USA Business October 13, 2022
COVID-19 vaccine maker Moderna’s stock rose the most in two months after Merck & Co. said it would exercise an option to work in partnership with the biotech on a messenger RNA cancer vaccine.Moderna will receive $250 million from Merck in exchange for joint development and... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
RTTNews USA Health October 12, 2022
Merck & Co., Inc. (), known as MSD outside the U.S. and Canada, announced Wednesday that Health Canada has granted approval for KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, as monotherapy for the adjuvant treatment of adults with renal cell carcinoma (RCC) at... + más
Study: Too few kids with sickle cell get stroke screen, care | Associated Press
CNBC USA Health October 12, 2022
Pipettes are seen at the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts, U.S., on Tuesday, Nov. 14, 2017. Moderna this week started testingAdam Glanzman Bloomberg Getty Images and will jointly develop and sell a cancer vaccine that is personalized for individual... + más
Moderna surges as Merck ramps up collaboration on cancer vaccine | The Boston Globe
Forbes USA Business October 10, 2022
A typical accountant or a superhero?Dreamstime Finance and accounting professionals may not be the most exciting people. Indeed, the clichéd Bob from Accounting is known to be a dry, bland character who crunches numbers all day and has no life. He has no cape and does not... + más
Monday’s high school roundup: Biddeford field hockey coach gets 100th win | Portland Press Herald
The Advocate USA Business October 04, 2022
A major international pharmaceutical company has spent more than $1 million to convert a North Baton Rouge veterinary medicine manufacturing facility into a plant that makes ear tags for cattle.Merck Animal Health said 33 people work in the plant at 2667 W. Dual St., roughly the... + más
How to change AirPods Pro ear tips and run the custom fit test | 9to5Mac
'This river is something else': American Queen brings tourists to Baton Rouge on the river | The Advocate
About iurex | Privacy Policy | Disclaimer |